Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

17 May 2025 (08:55 - 09:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Christophe de Terwangne

Cliniques Saint-Luc UCL, Brussels (Belgium)

3 More presentations in this session

Presentation thumbnail

Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction

Professor A. Sciacqua (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Professor C. Shim (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF

Doctor J. Butt (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

The Event

Event poster

Heart Failure 2025

17 May 2025 08:55 CET

You may be interested in

Congress Presentation

Age-related excess mortality in patients with heart failure with reduced ejection fraction compared with a matched general population cohort

Congress Presentation

Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication

Congress Session

The pandemic of ageing in heart failure: age, frailty, and cognition

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources